Literature DB >> 32298251

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.

Shikha Garg, Lindsay Kim, Michael Whitaker, Alissa O'Halloran, Charisse Cummings, Rachel Holstein, Mila Prill, Shua J Chai, Pam D Kirley, Nisha B Alden, Breanna Kawasaki, Kimberly Yousey-Hindes, Linda Niccolai, Evan J Anderson, Kyle P Openo, Andrew Weigel, Maya L Monroe, Patricia Ryan, Justin Henderson, Sue Kim, Kathy Como-Sabetti, Ruth Lynfield, Daniel Sosin, Salina Torres, Alison Muse, Nancy M Bennett, Laurie Billing, Melissa Sutton, Nicole West, William Schaffner, H Keipp Talbot, Clarissa Aquino, Andrea George, Alicia Budd, Lynnette Brammer, Gayle Langley, Aron J Hall, Alicia Fry.   

Abstract

Since SARS-CoV-2, the novel coronavirus that causes coronavirus disease 2019 (COVID-19), was first detected in December 2019 (1), approximately 1.3 million cases have been reported worldwide (2), including approximately 330,000 in the United States (3). To conduct population-based surveillance for laboratory-confirmed COVID-19-associated hospitalizations in the United States, the COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) was created using the existing infrastructure of the Influenza Hospitalization Surveillance Network (FluSurv-NET) (4) and the Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET). This report presents age-stratified COVID-19-associated hospitalization rates for patients admitted during March 1-28, 2020, and clinical data on patients admitted during March 1-30, 2020, the first month of U.S. surveillance. Among 1,482 patients hospitalized with COVID-19, 74.5% were aged ≥50 years, and 54.4% were male. The hospitalization rate among patients identified through COVID-NET during this 4-week period was 4.6 per 100,000 population. Rates were highest (13.8) among adults aged ≥65 years. Among 178 (12%) adult patients with data on underlying conditions as of March 30, 2020, 89.3% had one or more underlying conditions; the most common were hypertension (49.7%), obesity (48.3%), chronic lung disease (34.6%), diabetes mellitus (28.3%), and cardiovascular disease (27.8%). These findings suggest that older adults have elevated rates of COVID-19-associated hospitalization and the majority of persons hospitalized with COVID-19 have underlying medical conditions. These findings underscore the importance of preventive measures (e.g., social distancing, respiratory hygiene, and wearing face coverings in public settings where social distancing measures are difficult to maintain)† to protect older adults and persons with underlying medical conditions, as well as the general public. In addition, older adults and persons with serious underlying medical conditions should avoid contact with persons who are ill and immediately contact their health care provider(s) if they have symptoms consistent with COVID-19 (https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html) (5). Ongoing monitoring of hospitalization rates, clinical characteristics, and outcomes of hospitalized patients will be important to better understand the evolving epidemiology of COVID-19 in the United States and the clinical spectrum of disease, and to help guide planning and prioritization of health care system resources.

Entities:  

Year:  2020        PMID: 32298251      PMCID: PMC7755063          DOI: 10.15585/mmwr.mm6915e3

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  4 in total

1.  Estimating influenza disease burden from population-based surveillance data in the United States.

Authors:  Carrie Reed; Sandra S Chaves; Pam Daily Kirley; Ruth Emerson; Deborah Aragon; Emily B Hancock; Lisa Butler; Joan Baumbach; Gary Hollick; Nancy M Bennett; Matthew R Laidler; Ann Thomas; Martin I Meltzer; Lyn Finelli
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

2.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

3.  The US Influenza Hospitalization Surveillance Network.

Authors:  Sandra S Chaves; Ruth Lynfield; Mary Lou Lindegren; Joseph Bresee; Lyn Finelli
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

4.  Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-03       Impact factor: 17.586

  4 in total
  858 in total

1.  COVID-19 Susceptibility Among Latin People in El Paso, TX.

Authors:  Carina Cione; Ernesto Castaneda; Abby Ferdinando; Jhamiel Prince; Deziree Jackson; Emma Vetter; Sarah McCarthy
Journal:  SSRN       Date:  2020-06-12

2.  COVID-19, Racism, and Racial Disparities in Kidney Disease: Galvanizing the Kidney Community Response.

Authors:  Deidra C Crews; Tanjala S Purnell
Journal:  J Am Soc Nephrol       Date:  2020-07-13       Impact factor: 10.121

3.  COVID-19 and Vulnerable Populations in Sub-Saharan Africa.

Authors:  J A George; M R Maphayi; T Pillay
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4. 

Authors:  Paul Van Caeseele; Dana Bailey; Sarah E Forgie; Tanis C Dingle; Mel Krajden
Journal:  CMAJ       Date:  2020-12-07       Impact factor: 8.262

Review 5.  COVID-19 Pandemic and the Global Perspective of Turkish Thoracic Society.

Authors:  Nurdan Köktürk; Bahriye Oya İtil; Göksel Altınışık; Nalan Adıgüzel; Metin Akgün; Levent Akyıldız; Sedat Altın; Hüseyin Arıkan; Güngör Ateş; Pınar Ay; Nilüfer Aykaç; Cenk Babayiğit; Pınar Bostan; Güzin Cinel; Haluk Celaleddin Çalışır; Pınar Çelik; Pelin Duru Çetinkaya; Elif Dağlı; Ahmet Uğur Demir; Canan Demir; Öner Dikensoy; Ebru Çakır Edis; Osman Elbek; Münevver Erdinç; Begüm Ergan; A Füsun Öner Eyüboğlu; Bilun Gemicioğlu; Tuncay Göksel; Erkmen Gülhan; Ökkeş Gültekin; Canan Gündüz Gürkan; Alev Gürgün; Yavuz Havlucu; Ozen K Başoğlu; Sait Karakurt; Zuhal Karakurt; Oğuz Kılınç; Ali Kocabaş; Seval Kul; Benan Müsellim; Sibel Naycı; Metin Özkan; Özgün Pınarer; Cüneyt Saltürk; Abdulsamet Sandal; Abdullah Sayıner; Elif Şen; Gökçen Ömeroğlu Şimşek; Bülent Taner Karadağ; Fatma Tokgöz Akyıl; Zehra Nur Töreyin; Eyüp Sabri Uçan; Filiz Çağla Uyanusta Küçük; Ayhan Varol; Yeşim Yasin; Tekin Yıldız; A Arzu Yorgancıoğlu; Hasan Bayram
Journal:  Turk Thorac J       Date:  2020-11-01

Review 6.  [Obesity in the COVID era: A global health challenge].

Authors:  Miguel A Rubio Herrera; Irene Bretón Lesmes
Journal:  Endocrinol Diabetes Nutr       Date:  2020-10-21

7.  Social Determinants of Health and Implementation Research: Lessons from the COVID-19 Pandemic.

Authors:  William T Riley; George A Mensah
Journal:  Ethn Dis       Date:  2021-01-21       Impact factor: 1.847

8.  COVID-19 challenge: proactive management of a Tertiary University Hospital in Veneto Region, Italy.

Authors:  Giovanni Carretta; Cristina Contessa; Deris Gianni Boemo; Greta Bordignon; Silvia Eugenia Bennici; Stefano Merigliano; Margherita Boschetto; Alfio Capizzi; Annamaria Cattelan; Francesco Causin; Vito Cianci; Luciano Flor; Alberto Friziero; Paolo Navalesi; Maria Vittoria Nesoti; Anna Maria Saieva; Maria Scapellato; Ivo Tiberio; Roberto Vettor; Andrea Vianello; Renato Salvador; Daniele Donato
Journal:  Pathog Glob Health       Date:  2020-08-23       Impact factor: 2.894

9.  C-reactive protein and albumin association with mortality of hospitalised SARS-CoV-2 patients: A tertiary hospital experience.

Authors:  Ayman S Bannaga; Maria Tabuso; Alexia Farrugia; Subashini Chandrapalan; Karenjit Somal; Voon Kune Lim; Shahd Mohamed; Gohar J Nia; Jayan Mannath; John Lh Wong; Angela Noufaily; Benjamin R Disney; Ramesh P Arasaradnam
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

10.  Presentation and Outcomes of Patients with ESKD and COVID-19.

Authors:  Anthony M Valeri; Shelief Y Robbins-Juarez; Jacob S Stevens; Wooin Ahn; Maya K Rao; Jai Radhakrishnan; Ali G Gharavi; Sumit Mohan; S Ali Husain
Journal:  J Am Soc Nephrol       Date:  2020-05-28       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.